The telehealth company Hims & Hers said it will no longer sell a compounded version of Novo Nordisk's Wegovy pill, just days after announcing the new product. The move comes after Novo, which launched its ...
Click on the "Follow" button below and you'll get the latest news from Endpoints News via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Endpoints News title: Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.